Curis, Inc. (CRIS) Social Stream



Curis, Inc. (CRIS): $0.56

0.05 (+9.96%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CRIS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 384

in industry

CURIS INC (CRIS) Price Targets From Analysts

Use the tables below to see what analysts covering CURIS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-02-28 4 $24 $15 $20.25 $0.663 2954.3%
2022-03-22 4 $22 $12 $17.25 $0.663 2501.81%
2022-04-01 4 $22 $12.001 $17.25 $0.663 2501.81%
2022-04-05 4 $20 $4 $12.25 $0.663 1747.66%
2022-06-06 3 $16 $4 $10 $0.663 1408.3%
2022-08-05 3 $16 $3 $9.5 $0.663 1332.88%
2022-10-10 3 $16 $16 $16 $0.663 2313.27%
2022-11-10 3 $9 $9 $9 $0.663 1257.47%
2022-12-13 3 $9 $3 $6 $0.663 804.98%

The Trend in the Analyst Price Target


Over the past 22 months, CRIS's average price target has gone down $9.75.

Over the past 38 weeks, CRIS's average upside potential has been 1,014.98%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-05 4 20 4 12.25 1.500 716.67%
2022-06-06 3 16 4 10.00 0.865 1056.07%
2022-08-05 3 16 3 9.50 1.000 850%
2022-08-05 3 16 16 16.00 1.000 1500%
2022-08-05 2 16 16 16.00 1.000 1500%

CRIS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


Over the past 43 weeks, CRIS's average broker recommendation rating worsened by 0.42.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, CURIS INC's upside potential (average analyst target price relative to current price) is greater than 1179.84% of them.
  • To contextualize these metrics, consider that out of all US stocks, CURIS INC's number of analysts covering the stock is greater than 139.91% of them.
  • CURIS INC's variance in analysts' estimates is lower than -604.76% of stocks in the small market cap category.
  • In terms of how CURIS INC fares relative to Healthcare stocks, note that its average analyst price target is greater than 283.74% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CURIS INC are AGEN, PTE, and ACOR.

Is CRIS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8065 seconds.